NanoViricides, Inc.
NNVC
$1.11
$0.021.84%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.04% | -14.14% | -2.30% | -0.09% | -5.18% |
| Total Depreciation and Amortization | -11.04% | -2.00% | 2.11% | 2.18% | 1.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.95% | 0.54% | -42.34% | -44.21% | -45.91% |
| Change in Net Operating Assets | -133.55% | -97.95% | -76.65% | -92.05% | -63.78% |
| Cash from Operations | 3.37% | -34.25% | -30.40% | -34.00% | -33.22% |
| Capital Expenditure | 51.56% | 63.60% | -137.70% | -150.46% | -68.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 51.56% | 63.60% | -137.70% | -150.46% | -68.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.03% | 69.76% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.03% | 69.76% | -- | -- | 20,394.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.69% | 3.37% | 88.82% | 79.25% | 47.83% |